COMPANY
Solute Guard Therapeutics
From press sources: Solute Guard Therapeutics is an early-stage biopharma company developing monoclonal antibodies for chronic inflammatory diseases, including Sjogren disease and lymphoid rheumatoid arthritis, directed at a lactate transporter involved in ectopic lymphoid structures. Source